The opinion article, entitled “Blended finance solutions to the NCD gap,” examines the current burden of NCDs globally and the inadequate mechanisms for financing NCD care. Our CEO Dr. Andrea Feigl makes the case for why investment in NCDs should be a priority despite the challenges posed by the COVID-19 pandemic and elaborates on specific blended finance instruments that can kickstart a more effective response to the massive burden posed by these diseases.
